Global Animal Genetics Market was valued at USD XX Billion in the year 2020. Global Animal Genetics Market is further estimated to grow at a CAGR of XX% from 2021 to 2030 it will reach USD XX Billion by the year 2030. The North America region holds the highest market share in 2020 and the Asia Pacific is considered as the fastest growing market in the forecasted period. At a country level, US, China are projected to grow strongly in the coming years due to increasing density of population and funding through Research and Development.
The Global Animal Genetics Report 2020-2030 covers market opportunities and challenges, key market regulations’ information, analysis of new products from the market players and key market trends, market share analysis for key players, supply chain and value chain analysis, product and Material trends, pricing analysis, emerging applications, technologies and major recent developments. This information has also been provided for the major country markets in these regions. Market shares, size and growth potential are assessed for these major country markets. Market opportunities, challenges, government regulations, market share analysis by major competitors, recent major market developments (product launches, M&A, partnerships, etc.) and other information have been covered for the major country markets listed in this section.
On the basis of Type, the market is divided as Porcine, Bovine, Poultry, Canine. In which Porcine for the largest market share due to increasing demand in future market trends. Regional breakdown and deep analysis of each of the aforesaid segments is included for North America, Europe, Asia-Pacific, and ROW.
Market player analysis of major companies such as Genus Plc; Envigo Corporation; Topigs Norsvin; CRV Holding B.V; Groupe Grimaud La Corbiere SA; Hendrix Genetics BV; Neogen Corporation; Zoetis, Inc; URUS; Animal Genetics, Inc., and others.
| Particular | Scope |
|---|---|
| Region |
|
| Historic Year | 2015 tо 2019 |
| Estimated Year | 2020 |
| Forecast Year | 2021 tо 2029 |
1 INTRODUCTION
1.1 OBJECTIVES
1.2 MARKET DEFINITION
1.2.1 MARKET SCOPE
1.3 RESEARCH METHODOLOGY
1.3.1 SECONDARY DATA
1.3.2 PRIMARY DATA
1.3.3 MARKET SIZE ESTIMATION
1.3.4 MARKET BREAKDOWN AND DATA TRIANGULATION
1.4 STAKEHOLDERS
1.5 CURRENCY
1.6 RESEARCH ASSUMPTIONS
1.7 LIMITATION
2 EXECUTIVE SUMMARY
3 MARKET OUTLOOK
3.1 INTRODUCTION
3.2 DROC MATRIX
3.3 MARKET CHALLENGES
3.4 MARKET SHARE ANALYSIS
3.5 COST STRUCTURE ANALYSIS
3.6 VALUE CHAIN ANALYSIS
3.7 COVID-19 IMPACT ANALYSES
4 INDUSTRY TRENDS
4.1 INTRODUCTION
4.2 PESTEL ANALYSIS
4.3 PORTER’S FIVE FORCES MODEL
4.3.1 DEGREE OF COMPETITION
4.3.2 BARGAINING POWER OF BUYERS
4.3.3 BARGAINING POWER OF SUPPLIERS
4.3.4 THREAT FROM SUBSTITUTES
4.3.5 THREAT FROM NEW ENTRANTS
5 ANIMAL GENETICS TYPE ANALYSIS
5.1 INTRODUCTION
5.2 HISTORICAL MARKET TYPE ANALYSIS, 2015-2019
5.3 CURRENT AND FUTURE MARKET VALUE (MILLION) PROJECTIONS, 2020–2030
5.4 Y-O-Y GROWTH TREND ANALYSIS
5.5 POULTRY
5.6 PORCINE
5.7 BOVINE
5.8 CANINE
5.9 OTHERS
6 ANIMAL GENETICS MARKET GENETIC MATERIAL ANALYSIS
6.1 INTRODUCTION
6.2 HISTORICAL MARKET GENETIC MATERIAL ANALYSIS, 2015-2019
6.3 CURRENT AND FUTURE MARKET VALUE (MILLION) PROJECTIONS, 2020–2030
6.4 Y-O-Y GROWTH TREND ANALYSIS
6.5 SEMEN
6.5.1 BOVINE SEMEN
6.5.2 PORCINE SEMEN
6.5.3 EQUINE SEMEN
6.5.4 CANINE SEMEN
6.6 EMBRYOS
6.6.1 BOVINE EMBRYOS
6.6.2 EQUINE EMBRYOS
7 ANIMAL GENETICS MARKET APPLICATION ANALYSIS
7.1 INTRODUCTION
7.2 HISTORICAL MARKET APPLICATION ANALYSIS, 2015-2019
7.3 CURRENT AND FUTURE MARKET VALUE (MILLION) PROJECTIONS, 2020–2030
7.4 Y-O-Y GROWTH TREND ANALYSIS
7.5 DNA TYPING
7.6 GENETIC TRAIT TESTS
7.7 GENETIC DISEASE TESTS
7.8 OTHER (PRENATAL TESTING, DIAGNOSTIC TESTING, PREDICTIVE AND PRESYMPTOMATIC TESTING, FORENSIC TESTING)
8 GLOBAL ANIMAL GENETICS REGIONAL ANALYSIS
8.1 INTRODUCTION
8.2 NORTH AMERICA
8.2.1 NORTH AMERICA HISTORICAL MARKET COUNTRY ANALYSIS, 2015-2019
8.2.2 CURRENT AND FUTURE MARKET VALUE (MILLION) PROJECTIONS, 2020–2030
8.2.3 Y-O-Y GROWTH TREND ANALYSIS
8.2.3.1 U.S.
8.2.3.2 Canada
8.2.3.3 Mexico
8.3 ASIA-PACIFIC
8.3.1 APAC HISTORICAL MARKET COUNTRY ANALYSIS, 2015-2019
8.3.2 Y-O-Y GROWTH TREND ANALYSIS
8.3.2.1 China
8.3.2.2 Japan
8.3.2.3 Korea
8.3.2.4 India
8.3.2.5 Southeast Asia
8.4 MIDDLE EAST AND AFRICA
8.4.1 MIDDLE EAST AND AFRICA HISTORICAL MARKET COUNTRY ANALYSIS, 2015-2019
8.4.2 CURRENT AND FUTURE MARKET VALUE (MILLION) PROJECTIONS, 2020–2030
8.4.3 Y-O-Y GROWTH TREND ANALYSIS
8.4.3.1 Saudi Arabia
8.4.3.2 UAE
8.4.3.3 Egypt
8.4.3.4 Nigeria
8.4.3.5 South Africa
8.5 EUROPE
8.5.1 EUROPE HISTORICAL MARKET COUNTRY ANALYSIS, 2015-2019
8.5.2 CURRENT AND FUTURE MARKET VALUE (MILLION) PROJECTIONS, 2020–2030
8.5.3 Y-O-Y GROWTH TREND ANALYSIS
8.5.3.1 Germany
8.5.3.2 France
8.5.3.3 UK
8.5.3.4 Russia
8.5.3.5 Italy
8.6 SOUTH AMERICA
8.6.1 SOUTH AMERICA HISTORICAL MARKET COUNTRY ANALYSIS, 2015-2019
8.6.2 CURRENT AND FUTURE MARKET VALUE (MILLION) PROJECTIONS, 2020–2030
8.6.3 Y-O-Y GROWTH TREND ANALYSIS
8.6.3.1 Brazil
8.6.3.2 Argentina
8.6.3.3 Columbia
9 MARKET PLAYERS
9.1 GENUS PLC
9.1.1 BUSINESS OVERVIEW:
9.1.2 PRODUCT PORTFOLIO
9.1.3 RECENT DEVELOPMENTS
9.1.4 SWOT ANALYSIS:
9.2 ENVIGO CORPORATION
9.3 TOPIGS NORSVIN
9.4 CRV HOLDING B.V
9.5 GROUPE GRIMAUD LA CORBIERE SA
9.6 HENDRIX GENETICS BV
9.7 NEOGEN CORPORATION
9.8 ZOETIS, INC
9.9 URUS
9.10 ANIMAL GENETICS, INC.
9.11 ZOETIS INC.
9.12 VETGEN, L.L.C
9.13 EW GROUP GMBH
9.14 NZ BRASIL GENETICS PRODUCAO ANIMAL, LTD.
10 ABOUT US
FIGURE 1 RESEARCH METHODOLOGY
FIGURE 2 WORLD ANIMAL GENETICS ESTIMATED AND PROJECTED MARKET, 2020–2030, (USD MILLION)
FIGURE 3 WORLD ANIMAL GENETICS ESTIMATED AND PROJECTED MARKET, 2020–2030, (USD MILLION)
FIGURE 4 MARKET OVERVIEW
FIGURE 5 ANIMAL GENETICS EVOLUTION
FIGURE 6 MARKET SEGMENTATION
FIGURE 7 MARKET SHARE ANALYSIS
FIGURE 8 VALUE CHAIN ANALYSIS
FIGURE 9 PORTER’S FIVE FORCES ANALYSIS
FIGURE 10 WORLD ANIMAL GENETICS ESTIMATED AND PROJECTED TYPE ANALYSIS, 2020–2030, (USD MILLION)
FIGURE 11 Y-O-Y GROWTH TREND ANALYSIS BY TYPE
FIGURE 12 WORLD ANIMAL GENETICS ESTIMATED AND PROJECTED MATERIAL ANALYSIS, 2020–2030, (USD MILLION)
FIGURE 13 Y-O-Y GROWTH TREND ANALYSIS BY MATERIAL
FIGURE 14 WORLD ANIMAL GENETICS ESTIMATED AND PROJECTED TESTING SERVICES ANALYSIS, 2020–2030, (USD MILLION)
FIGURE 15 Y-O-Y GROWTH TREND ANALYSIS BY TESTING SERVICES
FIGURE 16 WORLD ANIMAL GENETICS VOLUME SHARE ESTIMATED AND PROJECTED REGIONAL ANALYSIS, 2020–2030, (USD MILLION)
FIGURE 17 MARKET OVERVIEW REGIONAL ANALYSIS, 2020–2030, (USD MILLION)
FIGURE 18 NORTH AMERICA ANIMAL GENETICS ESTIMATED AND PROJECTED COUNTRY ANALYSIS, 2020–2030, (USD MILLION)
FIGURE 19 NORTH AMERICA ANIMAL GENETICS ESTIMATED AND PROJECTED TYPE ANALYSIS, 2020–2030, (USD MILLION)
FIGURE 20 NORTH AMERICA ANIMAL GENETICS ESTIMATED AND PROJECTED MATERIAL ANALYSIS, 2020–2030, (USD MILLION)
FIGURE 21 NORTH AMERICA ANIMAL GENETICS ESTIMATED AND PROJECTED TESTING SERVICES ANALYSIS, 2020–2030, (USD MILLION)
FIGURE 22 U.S. ANIMAL GENETICS ESTIMATED AND PROJECTED TYPE ANALYSIS, 2020–2030, (USD MILLION)
FIGURE 23 U.S. ANIMAL GENETICS ESTIMATED AND PROJECTED TESTING SERVICES ANALYSIS, 2020–2030, (USD MILLION)
FIGURE 24 CANADA ANIMAL GENETICS ESTIMATED AND PROJECTED TYPE ANALYSIS, 2020–2030, (USD MILLION)
FIGURE 25 CANADA ANIMAL GENETICS ESTIMATED AND PROJECTED TESTING SERVICES ANALYSIS, 2020–2030, (USD MILLION)
FIGURE 26 EUROPE ANIMAL GENETICS ESTIMATED AND PROJECTED COUNTRY ANALYSIS, 2020–2030, (USD MILLION)
FIGURE 27 EUROPE ANIMAL GENETICS ESTIMATED AND PROJECTED TYPE ANALYSIS, 2020–2030, (USD MILLION)
FIGURE 28 EUROPE ANIMAL GENETICS ESTIMATED AND PROJECTED MATERIAL ANALYSIS, 2020–2030, (USD MILLION)
FIGURE 29 EUROPE ANIMAL GENETICS ESTIMATED AND PROJECTED TESTING SERVICES ANALYSIS, 2020–2030, (USD MILLION)
FIGURE 30 U.K. ANIMAL GENETICS ESTIMATED AND PROJECTED TYPE ANALYSIS, 2020–2030, (USD MILLION)
FIGURE 31 U.K. ANIMAL GENETICS ESTIMATED AND PROJECTED TESTING SERVICES ANALYSIS, 2020–2030, (USD MILLION)
FIGURE 32 GERMANY ANIMAL GENETICS ESTIMATED AND PROJECTED TYPE ANALYSIS, 2020–2030, (USD MILLION)
FIGURE 33 GERMANY ANIMAL GENETICS ESTIMATED AND PROJECTED TESTING SERVICES ANALYSIS, 2020–2030, (USD MILLION)
FIGURE 34 FRANCE ANIMAL GENETICS ESTIMATED AND PROJECTED TYPE ANALYSIS, 2020–2030, (USD MILLION)
FIGURE 35 FRANCE ANIMAL GENETICS ESTIMATED AND PROJECTED TESTING SERVICES ANALYSIS, 2020–2030, (USD MILLION)
FIGURE 36 REST OF EUROPE ANIMAL GENETICS ESTIMATED AND PROJECTED TYPE ANALYSIS, 2020–2030, (USD MILLION)
FIGURE 37 REST OF EUROPE ANIMAL GENETICS ESTIMATED AND PROJECTED TESTING SERVICES ANALYSIS, 2020–2030, (USD MILLION)
FIGURE 38 APAC ANIMAL GENETICS ESTIMATED AND PROJECTED COUNTRY ANALYSIS, 2020–2030, (USD MILLION)
FIGURE 39 APAC ANIMAL GENETICS ESTIMATED AND PROJECTED TYPE ANALYSIS, 2020–2030, (USD MILLION)
FIGURE 40 APAC ANIMAL GENETICS ESTIMATED AND PROJECTED MATERIAL ANALYSIS, 2020–2030, (USD MILLION)
FIGURE 41 APAC ANIMAL GENETICS ESTIMATED AND PROJECTED TESTING SERVICES ANALYSIS, 2020–2030, (USD MILLION)
FIGURE 42 JAPAN ANIMAL GENETICS ESTIMATED AND PROJECTED TYPE ANALYSIS, 2020–2030, (USD MILLION)
FIGURE 43 JAPAN ANIMAL GENETICS ESTIMATED AND PROJECTED TESTING SERVICES ANALYSIS, 2020–2030, (USD MILLION)
FIGURE 44 CHINA ANIMAL GENETICS ESTIMATED AND PROJECTED TYPE ANALYSIS, 2020–2030, (USD MILLION)
FIGURE 45 CHINA ANIMAL GENETICS ESTIMATED AND PROJECTED TESTING SERVICES ANALYSIS, 2020–2030, (USD MILLION)
FIGURE 46 INDIA ANIMAL GENETICS ESTIMATED AND PROJECTED TYPE ANALYSIS, 2020–2030, (USD MILLION)
FIGURE 47 INDIA ANIMAL GENETICS ESTIMATED AND PROJECTED TESTING SERVICES ANALYSIS, 2020–2030, (USD MILLION)
FIGURE 48 REST OF APAC ANIMAL GENETICS ESTIMATED AND PROJECTED TYPE ANALYSIS, 2020–2030, (USD MILLION)
FIGURE 49 REST OF APAC ANIMAL GENETICS ESTIMATED AND PROJECTED TESTING SERVICES ANALYSIS, 2020–2030, (USD MILLION)
FIGURE 50 ROW ANIMAL GENETICS ESTIMATED AND PROJECTED COUNTRY ANALYSIS, 2020–2030, (USD MILLION)
FIGURE 51 ROW ANIMAL GENETICS ESTIMATED AND PROJECTED TYPE ANALYSIS, 2020–2030, (USD MILLION)
FIGURE 52 ROW ANIMAL GENETICS ESTIMATED AND PROJECTED MATERIAL ANALYSIS, 2020–2030, (USD MILLION)
FIGURE 53 ROW ANIMAL GENETICS ESTIMATED AND PROJECTED TESTING SERVICES ANALYSIS, 2020–2030, (USD MILLION)
FIGURE 54 MIDDLE EAST ANIMAL GENETICS ESTIMATED AND PROJECTED TYPE ANALYSIS, 2020–2030, (USD MILLION)
FIGURE 55 MIDDLE EAST ANIMAL GENETICS ESTIMATED AND PROJECTED TESTING SERVICES ANALYSIS, 2020–2030, (USD MILLION)
FIGURE 56 AFRICA ANIMAL GENETICS ESTIMATED AND PROJECTED TYPE ANALYSIS, 2020–2030, (USD MILLION)
FIGURE 57 AFRICA ANIMAL GENETICS ESTIMATED AND PROJECTED TESTING SERVICES ANALYSIS, 2020–2030, (USD MILLION)
FIGURE 58 LATIN AMERICA ANIMAL GENETICS ESTIMATED AND PROJECTED TYPE ANALYSIS, 2020–2030, (USD MILLION)
FIGURE 59 LATIN AMERICA ANIMAL GENETICS ESTIMATED AND PROJECTED TESTING SERVICES ANALYSIS, 2020–2030, (USD MILLION)
TABLE 1 WORLD ANIMAL GENETICS ESTIMATED AND PROJECTED REGIONAL ANALYSIS, 2020–2030 (USD MILLION)
TABLE 2 WORLD ANIMAL GENETICS BENCHMARK MARKET REVENUE ANALYSIS BY TYPE, 2015-2019, (USD MILLION)
TABLE 3 WORLD ANIMAL GENETICS ESTIMATED AND PROJECTED TYPE ANALYSIS, 2020–2030 (USD MILLION)
TABLE 4 WORLD ANIMAL GENETICS BENCHMARK MARKET REVENUE ANALYSIS BY MATERIAL, 2015-2019, (USD MILLION)
TABLE 5 WORLD ANIMAL GENETICS ESTIMATED AND PROJECTED MATERIAL ANALYSIS, 2020–2030 (USD MILLION)
TABLE 6 WORLD ANIMAL GENETICS BENCHMARK MARKET REVENUE ANALYSIS BY TESTING SERVICES, 2015-2019, (USD MILLION)
TABLE 7 WORLD ANIMAL GENETICS ESTIMATED AND PROJECTED TESTING SERVICES ANALYSIS, 2020–2030 (USD MILLION)
TABLE 8 NORTH AMERICA WORLD ANIMAL GENETICS BENCHMARK MARKET REVENUE ANALYSIS BY COUNTRY, 2015-2019, (USD MILLION)
TABLE 9 NORTH AMERICA ANIMAL GENETICS ESTIMATED AND PROJECTED COUNTRY ANALYSIS, 2020–2030 (USD MILLION)
TABLE 10 NORTH AMERICA ANIMAL GENETICS ESTIMATED AND PROJECTED TYPE ANALYSIS, 2020–2030 (USD MILLION)
TABLE 11 NORTH AMERICA ANIMAL GENETICS ESTIMATED AND PROJECTED MATERIAL ANALYSIS, 2020–2030 (USD MILLION)
TABLE 12 NORTH AMERICA ANIMAL GENETICS ESTIMATED AND PROJECTED TESTING SERVICES ANALYSIS, 2020–2030 (USD MILLION)
TABLE 13 U.S. ANIMAL GENETICS ESTIMATED AND PROJECTED TYPE ANALYSIS, 2020–2030 (USD MILLION)
TABLE 14 U.S. ANIMAL GENETICS ESTIMATED AND PROJECTED TESTING SERVICES ANALYSIS, 2020–2030 (USD MILLION)
TABLE 15 CANADA ANIMAL GENETICS ESTIMATED AND PROJECTED TYPE ANALYSIS, 2020–2030 (USD MILLION)
TABLE 16 CANADA ANIMAL GENETICS ESTIMATED AND PROJECTED TESTING SERVICES ANALYSIS, 2020–2030 (USD MILLION)
TABLE 17 EUROPE WORLD ANIMAL GENETICS BENCHMARK MARKET REVENUE ANALYSIS BY COUNTRY, 2015-2019, (USD MILLION)
TABLE 18 EUROPE ANIMAL GENETICS ESTIMATED AND PROJECTED COUNTRY ANALYSIS, 2020–2030 (USD MILLION)
TABLE 19 EUROPE ANIMAL GENETICS ESTIMATED AND PROJECTED TYPE ANALYSIS, 2020–2030 (USD MILLION)
TABLE 20 EUROPE ANIMAL GENETICS ESTIMATED AND PROJECTED MATERIAL ANALYSIS, 2020–2030 (USD MILLION)
TABLE 21 EUROPE ANIMAL GENETICS ESTIMATED AND PROJECTED TESTING SERVICES ANALYSIS, 2020–2030 (USD MILLION)
TABLE 22 U.K. ANIMAL GENETICS ESTIMATED AND PROJECTED TYPE ANALYSIS, 2020–2030 (USD MILLION)
TABLE 23 U.K. ANIMAL GENETICS ESTIMATED AND PROJECTED TESTING SERVICES ANALYSIS, 2020–2030 (USD MILLION)
TABLE 24 GERMANY ANIMAL GENETICS ESTIMATED AND PROJECTED TYPE ANALYSIS, 2020–2030 (USD MILLION)
TABLE 25 GERMANY ANIMAL GENETICS ESTIMATED AND PROJECTED TESTING SERVICES ANALYSIS, 2020–2030 (USD MILLION)
TABLE 26 FRANCE ANIMAL GENETICS ESTIMATED AND PROJECTED TYPE ANALYSIS, 2020–2030 (USD MILLION)
TABLE 27 FRANCE ANIMAL GENETICS ESTIMATED AND PROJECTED TESTING SERVICES ANALYSIS, 2020–2030 (USD MILLION)
TABLE 28 REST OF EUROPE ANIMAL GENETICS ESTIMATED AND PROJECTED TYPE ANALYSIS, 2020–2030 (USD MILLION)
TABLE 29 REEST OF EUROPE ANIMAL GENETICS ESTIMATED AND PROJECTED TESTING SERVICES ANALYSIS, 2020–2030 (USD MILLION)
TABLE 30 ASIA-PACIFIC WORLD ANIMAL GENETICS BENCHMARK MARKET REVENUE ANALYSIS BY COUNTRY, 2015-2019, (USD MILLION)
TABLE 31 ASIA-PACIFIC ANIMAL GENETICS ESTIMATED AND PROJECTED COUNTRY ANALYSIS, 2020–2030 (USD MILLION)
TABLE 32 ASIA-PACIFIC ANIMAL GENETICS ESTIMATED AND PROJECTED TYPE ANALYSIS, 2020–2030 (USD MILLION)
TABLE 33 ASIA-PACIFIC ANIMAL GENETICS ESTIMATED AND PROJECTED MATERIAL ANALYSIS, 2020–2030 (USD MILLION)
TABLE 34 ASIA-PACIFIC ANIMAL GENETICS ESTIMATED AND PROJECTED TESTING SERVICES ANALYSIS, 2020–2030 (USD MILLION)
TABLE 35 JAPAN ANIMAL GENETICS ESTIMATED AND PROJECTED TYPE ANALYSIS, 2020–2030 (USD MILLION)
TABLE 36 JAPAN ANIMAL GENETICS ESTIMATED AND PROJECTED TESTING SERVICES ANALYSIS, 2020–2030 (USD MILLION)
TABLE 37 CHINA ANIMAL GENETICS ESTIMATED AND PROJECTED TYPE ANALYSIS, 2020–2030 (USD MILLION)
TABLE 38 CHINA ANIMAL GENETICS ESTIMATED AND PROJECTED TESTING SERVICES ANALYSIS, 2020–2030 (USD MILLION)
TABLE 39 INDIA ANIMAL GENETICS ESTIMATED AND PROJECTED TYPE ANALYSIS, 2020–2030 (USD MILLION)
TABLE 40 INDIA ANIMAL GENETICS ESTIMATED AND PROJECTED TESTING SERVICES ANALYSIS, 2020–2030 (USD MILLION)
TABLE 41 REST OF APAC ANIMAL GENETICS ESTIMATED AND PROJECTED TYPE ANALYSIS, 2020–2030 (USD MILLION)
TABLE 42 REST OF APAC ANIMAL GENETICS ESTIMATED AND PROJECTED TESTING SERVICES ANALYSIS, 2020–2030 (USD MILLION)
TABLE 43 ROW ANIMAL GENETICS BENCHMARK MARKET REVENUE ANALYSIS BY COUNTRY, 2015-2019, (USD MILLION)
TABLE 44 ROW ANIMAL GENETICS ESTIMATED AND PROJECTED COUNTRY ANALYSIS, 2020–2030 (USD MILLION)
TABLE 45 ROW ANIMAL GENETICS ESTIMATED AND PROJECTED TYPE ANALYSIS, 2020–2030 (USD MILLION)
TABLE 46 ROW ANIMAL GENETICS ESTIMATED AND PROJECTED MATERIAL ANALYSIS, 2020–2030 (USD MILLION)
TABLE 47 ROW ANIMAL GENETICS ESTIMATED AND PROJECTED TESTING SERVICES ANALYSIS, 2020–2030 (USD MILLION)
TABLE 48 MIDDLE EAST ANIMAL GENETICS ESTIMATED AND PROJECTED TYPE ANALYSIS, 2020–2030 (USD MILLION)
TABLE 49 MIDDLE EAST ANIMAL GENETICS ESTIMATED AND PROJECTED TESTING SERVICES ANALYSIS, 2020–2030 (USD MILLION)
TABLE 50 AFRICA ANIMAL GENETICS ESTIMATED AND PROJECTED TYPE ANALYSIS, 2020–2030 (USD MILLION)
TABLE 51 AFRICA ANIMAL GENETICS ESTIMATED AND PROJECTED TESTING SERVICES ANALYSIS, 2020–2030 (USD MILLION)
TABLE 52 LATIN AMERICA ANIMAL GENETICS ESTIMATED AND PROJECTED TYPE ANALYSIS, 2020–2030 (USD MILLION)
TABLE 53 LATIN AMERICA ANIMAL GENETICS ESTIMATED AND PROJECTED TESTING SERVICES ANALYSIS, 2020–2030 (USD MILLION)
Global Starch Capsule Market By Type (1, 2, 3, 4, 5, Other size), By Application (Pharmaceutical, Nutraceutical), By Country, and Manufacture - Industry Segment, Competition Scenario and Forecast by 2029
Global Iloprost Drugs Market By Type (Inhaled, Intravenous), By Application (Hospital, Clinic), By Country, and Manufacture - Industry Segment, Competition Scenario and Forecast by 2029
Global Antibiotic API Market By Type (Penicillins, Cephalosporins, Aminoglycosides, Tetracyclines, Quinolones, Macrolides, Lincomycins), By Application (Oral Medicine, Injection Medicine), By Country, and Manufacture - Industry Segment, Competition Scenario and Forecast by 2029
Global Zoladex Market By Type (1M Zoladex, 3M Zoladex), By Application (Prostate Cancer, Breast Cancer, Endometriosis, Fibroids), By Country, and Manufacture - Industry Segment, Competition Scenario and Forecast by 2029
Global Aminoglycosides Antibiotics Market By Type (Neomycin, Tobramycin, Gentamicin, Amikacin, Etimicin), By Application (Hospital, Clinic, Post Care Facility, Government & Military), By Country, and Manufacture - Industry Segment, Competition Scenario and Forecast by 2029
Global THF-OL Market By Type (R-3-THF-OL, S-3-THF-OL, Rac-3-THF-OL), By Application (Pesticide Intermediates, Pharmaceutical Intermediates), By Country, and Manufacture - Industry Segment, Competition Scenario and Forecast by 2029
Global Piperacillin Sodium (CAS 59703-84-3) Market By Type (Piperacillin, Piperacillin and Tazobactam), By Application (Piperacillin Sodium Injection, Piperacillin Sodium Compound Injection), By Country, and Manufacture - Industry Segment, Competition Scenario and Forecast by 2029
Global Beta-lactam and Beta-lactamase Inhibitors Market By Type (Penicillin, Cephalosporin, Carbapenem, Monobactam, Combination), By Application (Oral, Intravenous), By Country, and Manufacture - Industry Segment, Competition Scenario and Forecast by 2029
Global Notoginseng Root Extract Market By Type (Powder Extract, Liquid Extract), By Application (Pharmaceuticals, Cosmetics and Personal Care, Health Supplement Products), By Country, and Manufacture - Industry Segment, Competition Scenario and Forecast by 2029
Global Equine Supplement Products Market By Type (Proteins/Amino Acids, Vitamins, Enzymes, Electrolytes/Minerals), By Application (Veterinary Hospital Pharmacies, Retail Pharmacies), By Country, and Manufacture - Industry Segment, Competition Scenario and Forecast by 2029
Global Medicated Shampoo Market By Type (To Dandruff, Treatment of Psoriasis, Destroy Type, Head-to-head Type, Treat Allergic Reactions), By Application (Hypermarkets/Supermarkets, Convenience Stores, Online), By Country, and Manufacture - Industry Segment, Competition Scenario and Forecast by 2029
Global Cough Suppressant Drugs Market By Type (Dry Cough, Wet Cough), By Application (Hospital, Retail Pharmacy, Online Pharmacy), By Country, and Manufacture - Industry Segment, Competition Scenario and Forecast by 2029
Global Bacteriostatic Antibiotics Market By Type (Tetracycline, Doxycycline, Chloramphenicol, Erythromycin, Fusidic acid, Sulfonamides, Trimethoprim, Macrolides, Lincosamides), By Application (Hospitals, Clinics), By Country, and Manufacture - Industry Segment, Competition Scenario and Forecast by 2029
Global Hemodialysis Vascular Grafts Market By Type (Polyester, Polytetrafluoroethylene, Polyurethane, Biological Materials), By Application (Hospitals, Clinics), By Country, and Manufacture - Industry Segment, Competition Scenario and Forecast by 2029
Global Asthma and COPD Drug Market By Type (Bronchodilators, Anti-inflammatory Drugs, Monoclonal Antibodies, Combination Drugs), By Application (Asthma, COPD), By Country, and Manufacture - Industry Segment, Competition Scenario and Forecast by 2029
Global Famciclovir API Market By Type (Insourced, Outsourced), By Application (Tablet Product, Capsule Product), By Country, and Manufacture - Industry Segment, Competition Scenario and Forecast by 2029
Global Pharmaceuticals for Women\'s Health Market By Type (Granules, Pills, Powder, Tincture, Tablets, Capsule), By Application (Postmenopausal Osteoporosis, Endometriosis, Polycystic Ovarian Syndrome, Pregnancy Disorders), By Country, and Manufacture - Industry Segment, Competition Scenario and Forecast by 2029
Global Montelukast Intermediate Market By Type (GMP, Non-GMP), By Application (Asthma, Allergic Rhinitis, Bronchospasm, Urticaria), By Country, and Manufacture - Industry Segment, Competition Scenario and Forecast by 2029
Global Thyroid Disorder Market By Type (Hypothyroidism, Hyperthyroidism), By Application (Hospitals, Clinics), By Country, and Manufacture - Industry Segment, Competition Scenario and Forecast by 2029
Global Postoperative Pain Therapeutics Market By Type (Oral, Intramuscular, Intravenous), By Application (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), By Country, and Manufacture - Industry Segment, Competition Scenario and Forecast by 2029
sales@globalresearchview.com
UK +44020 8638 7098
Secure payments with
